U.S. top court declines to hear Rajaratnam appeal
WASHINGTON (Reuters) - The U.S. Supreme Court on Monday left intact the insider trading conviction of Galleon Group hedge fund founder Raj Rajaratnam.
The court declined to hear Rajaratnam’s appeal, meaning a June 2013 decision by the 2nd U.S. Circuit Court of Appeals in New York upholding the conviction is the final word in the case.
The appeals court rejected Rajaratnam’s argument that wiretap evidence was used improperly to convict him.
Rajaratnam is serving an 11-year prison term. A federal jury convicted him in May 2011 of nine counts of securities fraud and five counts of conspiracy.
The government said Rajaratnam, whose firm once managed $7 billion, made as much as $63.8 million in illicit profit from 2003 to March 2009 trading on stocks including eBay Inc, Goldman Sachs Group Inc and Google Inc.
Prosecutors said the Goldman trades included trades during the 2008 financial crisis, just after Rajaratnam got a tip from Goldman director Rajat Gupta of an infusion in the bank from Warren Buffett's Berkshire Hathaway Inc.
An insider trading trial involving charges against Rajaratnam’s younger brother Rengan, is expected to begin on Tuesday, also in Manhattan federal court. Since October 2009, 81 people have pleaded guilty or were convicted at trial in insider trading cases in Manhattan.
The case is Rajaratnam v. United States, U.S. Supreme Court, No. 13-1001.
(Reporting by Lawrence Hurley; Additional reporting by Nate Raymond and Jonathan Stempel; Editing by Howrad Goller)
- Tweet this
- Share this
- Digg this
- Preview: Basel fans baffled by new coach Sousa's switches
- Obama, Modi vow to boost strategic ties, create model for world
- Preview: Arsenal must now beat Galatasaray, says Cazorla
- China censors try to blunt Hong Kong protests, don't always succeed
- Police arrest 140 for religious clashes in Vadodara as Modi tours U.S.
Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce generic medicines poor people can afford, the medical charity Doctors Without Borders (MSF) said. Full Article | Full Coverage
China final HSBC PMI steady in September on stronger global demand but risks remain Full Article